Men with prostate cancer could benefit from hormone therapy, despite a risk for side effects.
Researchers at the University of California studied prostate cancer patients who underwent four months of hormone therapy and radiation, and found their cancer growth was slowed by as much as eight years when compared to men who did not undergo hormone therapy.
Hormone therapy lowers levels of cancer-fueling agents in the blood, but it can also be associated with bone loss, depression and cardiovascular risks when used long-term.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.